This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

NITI Aayog explores policies to boost India's medical and dental device manufacturing industry

NITI Aayog is exploring policy measures to improve the manufacturing capabilities of medical and dental devices in India. The meeting included domestic manufacturers, government officials, and experts from IIT Delhi and IIT Mumbai. Key challenges such as regulatory hurdles and cost disadvantages faced by Indian manufacturers were discussed extensively. The industry body AiMeD emphasized the need for simpler regulations and financial support for local manufacturers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OU16ieb
via IFTTT

HLL Lifecare launches eStore to expand direct-to-consumer reach

State-owned company HLL Lifecare launched HLL eStore, a digital platform aimed to expand access to its healthcare and wellness products across the country. The platform would be part of its broader digital transformation strategy, enabling customers, business partners and healthcare institutions to engage with the company through an integrated online marketplace. The eStore also offers medical products and supplies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XZRSFnY
via IFTTT

AYUSH sees rise in patents filings showcasing innovation growth; 4,077 applications filed from 2014 to 2026

Ayush-related Intellectual Property activity has seen substantial growth, with over 4,000 patent applications from 2014 to 2026. The Ministry of Ayush emphasises the increasing participation of individuals and institutions in this sector. Patent filings peaked post-COVID, reflecting a focus on research and innovation. Natural persons and educational institutions contributed significantly to the total filings and grants. The government continues to foster an enabling environment for traditional knowledge and scientific research.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lxD4gmf
via IFTTT

India needs 2.6 billion sq ft of healthcare space by 2035, says CBRE

India requires an expansion of its healthcare infrastructure with an additional 2.6 billion sq ft by 2035. This need arises due to an expected demand for nearly 2.9 million more hospital beds nationwide. Current statistics show India has only 1.6 hospital beds per 1,000 people, significantly less than the global average. Certain states face much lower hospital bed density compared to their disease burden, indicating unmet healthcare needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rfzT6tg
via IFTTT

Indian, German firms to collaborate on immunoglobulin products: Indian Embassy

Germany's Neovii Biotech and India's VINS Bioproducts will explore collaboration on manufacturing and commercialising immunoglobulin products, including anti-thymocyte globulin used in organ transplantation and certain blood disorders. Facilitated by the Indian Embassy in Berlin, the agreement involves technology transfer to India and could strengthen domestic capabilities in specialised biological products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VT6fGIw
via IFTTT

Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch

Biocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to launch Pebrilzo in early 2027 in the UK and EU, and in late 2028 in the US. In response to Genentech's patent infringement suit, the New Jersey court dismissed the case at Genentech's request. The details of the settlement agreement remain confidential between the companies involved.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NhPxSjv
via IFTTT

Novo Holdings, GIC, Axight look to back AIG Hospitals; Founders aim to pare 10-12% stake at Rs 24,000 cr valuation

Novo Holdings and GIC are discussing investing Rs 2,000-2,500 crore in AIG Hospitals based in Hyderabad. The investment reflects a growing interest among private equity firms in Indian healthcare. Founders of AIG Hospitals, Duvvur Nageshwar Reddy and Penmetsa Venkata Subbaraju, are planning a stake sale. AIG Hospitals has plans for a new facility in Visakhapatnam and aims to grow significantly.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/e4M9VTd
via IFTTT